NEW YORK (GenomeWeb) – Caris Life Sciences today announced the establishment of the Caris Centers of Excellence for Precision Medicine Network. It also announced the appointment of John Marshall, chief of hematology and oncology at Georgetown Lombardi Comprehensive Cancer Center, as chairman of the network.

The firm said in a statement that the network of cancer centers will work collaboratively to advance the delivery of tumor profiling and establish standards of care for molecular profiling in oncology. Network members other than Georgetown Lombardi were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.